Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy

[1]  B. Strom,et al.  Breast Cancer Receptor Status: Do Results from a Centralized Pathology Laboratory Agree with SEER Registry Reports? , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[2]  Kevin C Oeffinger,et al.  Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. , 2009, JAMA.

[3]  P. Hall,et al.  Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Ménard,et al.  Radiation Effects on Development of HER2-Positive Breast Carcinomas , 2007, Clinical Cancer Research.

[5]  A. Goldhirsch,et al.  Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Yan Liu,et al.  A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. , 2003, American journal of epidemiology.

[7]  Nilanjan Chatterjee,et al.  Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database , 2002, Breast Cancer Research and Treatment.

[8]  M. Stovall,et al.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Neuberg,et al.  Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Neuhausen,et al.  Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. , 2001, International journal of radiation oncology, biology, physics.

[11]  C. Shapiro,et al.  Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case‐Control Study , 2001, The breast journal.

[12]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[13]  S. Jeffrey,et al.  Management of breast cancer after Hodgkin's disease. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Fears,et al.  Graphical presentation of trends in rates. , 1995, American journal of epidemiology.

[15]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  B. Fisher,et al.  Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin's disease. , 1985, Acta radiologica. Oncology.

[17]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[18]  B. Macmahon,et al.  Menopause and breast cancer risk. , 1972, Journal of the National Cancer Institute.

[19]  N. Chatterjee,et al.  Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.